Cargando…
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Cancer stem cells are initiating cells of cancer and propagate its growth through self-renewal and differentiation of its daughter cells. CD133 is a cell surface antigen that is present on glioma stem cells and has been used to prospectively isolate glioma stem cells. We hypothesized that a major hi...
Autores principales: | Do, Angelique Sao-Mai Sy, Amano, Takayuki, Edwards, Lincoln A., Zhang, Lei, De Peralta-Venturina, Mariza, Yu, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378271/ https://www.ncbi.nlm.nih.gov/pubmed/32728617 http://dx.doi.org/10.1016/j.omto.2020.06.019 |
Ejemplares similares
-
CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
por: Tay, Angelique Sao-Mai Sy, et al.
Publicado: (2021) -
Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function
por: ZENG, SHAO-LIN, et al.
Publicado: (2015) -
Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells
por: Bacher, Nicole, et al.
Publicado: (2011) -
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics
por: Beltzig, Lea, et al.
Publicado: (2022) -
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)